Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Updates for media on the latest products, offerings and developments across our business.
May 31, 2018
探花合集 Biologics Supports New Methamphetamine Treatment. SOMERSET, N.J. 鈥 May 31, 2018 鈥 探花合集 Pharma Solutions, the leading global provider of advanced delivery technologies and development solu鈥
May 17, 2018
SOMERSET, N.J. 鈥 May 17, 2018 鈥 探花合集 Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, to鈥
May 14, 2018
探花合集 Biologics and Valerius Biopharma to Collaborate on Biosimilars. Somerset, N.J. 鈥 May 14, 2018 鈥 探花合集 Pharma Solutions, the leading global provider of advanced delivery technologies and de鈥
May 9, 2018
探花合集鈥檚 partner, Biohaven, announces it has Initiated Expanded Access Program for Sublingual BHV-0223 ZYDIS庐 Orally Dissolving Tablets for Patients with Amyotrophic Lateral Sclerosis (ALS)
Apr 19, 2018
探花合集 to Lead Multiple Workshops at Upcoming US GCSG Conference. SOMERSET, N.J. 鈥 April 19, 2018 鈥 探花合集 Pharma Solutions, the leading global provider of advanced delivery technologies and devel鈥
Apr 12, 2018
SOMERSET, N.J. 鈥 April 12, 2018 鈥 探花合集 Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, 鈥
Apr 11, 2018
SOMERSET, N.J. 鈥 April 10, 2018 鈥 探花合集 Pharma Solutions (Booth 1245), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer heal鈥
Mar 8, 2018
探花合集 To Discuss Potential Implications of Brexit on Clinical Supply. SOMERSET, N.J. 鈥 March 8, 2018 鈥 探花合集 Pharma Solutions, the leading global provider of advanced delivery technologies and d鈥
Mar 1, 2018
The 探花合集 Applied Drug Delivery Institute today announced that it is to hold a one-day symposium titled 鈥淪mart Drug Development & Design from Candidate to Phase I鈥 on Thursday, March 8, at Novartis鈥
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
